Topical application of a dual PI3K/mTOR inhibitor prevents anal carcinogenesis in a human papillomavirus mouse model of anal cancer

MLA

Brooks L. Rademacher, et al. “Topical Application of a Dual PI3K/MTOR Inhibitor Prevents Anal Carcinogenesis in a Human Papillomavirus Mouse Model of Anal Cancer.” European Journal of Cancer Prevention, vol. 28, Nov. 2019, pp. 483–91. EBSCOhost, https://doi.org/10.1097/cej.0000000000000505.

APA

Brooks L. Rademacher, Emily D LaCount, Evie Carchman, & Kristina A. Matkowskyj. (2019). Topical application of a dual PI3K/mTOR inhibitor prevents anal carcinogenesis in a human papillomavirus mouse model of anal cancer. European Journal of Cancer Prevention, 28, 483–491. https://doi.org/10.1097/cej.0000000000000505

Chicago

Brooks L. Rademacher, Emily D LaCount, Evie Carchman, and Kristina A. Matkowskyj. 2019. “Topical Application of a Dual PI3K/MTOR Inhibitor Prevents Anal Carcinogenesis in a Human Papillomavirus Mouse Model of Anal Cancer.” European Journal of Cancer Prevention 28 (November): 483–91. doi:10.1097/cej.0000000000000505.